ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
36.71
0.77%
US Tech 100
18,768.00
2.55%
S&P 500
5,520.66
1.55%
US Dollar vs CAD
1.38071
-0.31%
Bitcoin
66,058.19
-0.17%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSXV

  6. Vencan Gold (Tier2) (VCG) Share Price

Vencan Gold (Tier2)

Vencan Gold (Tier2) (VCG)

TSXV
0.00
0.00
( 0.00% )
Updated: -
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

VCG Latest News

More News

Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107

Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107 PR Newswire PLYMOUTH MEETING, Pa., July...

July 25 2024
PR Newswire (US)

INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024

INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024 PR Newswire PLYMOUTH MEETING, Pa., July 25, 2024 PLYMOUTH MEETING, Pa., July 25, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO...

July 25 2024
PR Newswire (US)

INO-3107 Awarded the Innovation Passport Designation Under U.K. Government's Innovative Licensing and Access Pathway

INO-3107 Awarded the Innovation Passport Designation Under U.K. Government's Innovative Licensing and Access Pathway PR Newswire PLYMOUTH MEETING, Pa., July 11, 2024 Award recognizes the...

July 11 2024
PR Newswire (US)

INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer

INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer PR Newswire PLYMOUTH MEETING, Pa., July 2, 2024 Mr. Egge brings over 25 years of biopharmaceutical experience building...

July 02 2024
PR Newswire (US)

INOVIO Reports Inducement Grant Under Inducement Plan

INOVIO Reports Inducement Grant Under Inducement Plan PR Newswire PLYMOUTH MEETING, Pa., July 1, 2024 PLYMOUTH MEETING, Pa., July 1, 2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology...

July 01 2024
PR Newswire (US)

INOVIO Added to Russell 2000® Index Effective July 1, 2024

INOVIO Added to Russell 2000® Index Effective July 1, 2024 PR Newswire PLYMOUTH MEETING, Pa., July 1, 2024 PLYMOUTH MEETING, Pa., July 1, 2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a...

July 01 2024
PR Newswire (US)

INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc.

INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc. PR Newswire PLYMOUTH MEETING, Pa., June 4, 2024 PLYMOUTH MEETING, Pa., June 4, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a...

June 04 2024
PR Newswire (US)

INOVIO Reports Inducement Grants Under Inducement Plan

INOVIO Reports Inducement Grants Under Inducement Plan PR Newswire PLYMOUTH MEETING, Pa., May 31, 2024 PLYMOUTH MEETING, Pa., May 31, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology...

May 31 2024
PR Newswire (US)

Form 8-K - Current report

May 28 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

May 22 2024
Edgar (US Regulatory)
Period †ChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GOODGood Gamer Entertainment Inc
$ 0.10
(150.00%)
1.3k
CSPNCarespan Health Inc
$ 0.035
(133.33%)
1,000
HMANHuntsman Exploration Inc
$ 0.055
(57.14%)
1,000
SOP.HSoperior Fertilizer Corp
$ 0.015
(50.00%)
41.8k
BOCABocana Resources Corp
$ 0.015
(50.00%)
1,000
NUGNulegacy Gold Corporation
$ 0.005
(-50.00%)
120.74k
RRM.HRoss River Minerals Inc
$ 0.025
(-50.00%)
30.74k
EVOC.PEvocati Capital Resources Inc
$ 0.045
(-47.06%)
13k
GITGitennes Exploration Inc
$ 0.055
(-45.00%)
10k
ENTGEntourage Health Corp
$ 0.01
(-33.33%)
6.08k
ADZNAdventus Mining Corporation
$ 0.51
(18.60%)
1.97M
MOGMogotes Metals Inc
$ 0.14
(7.69%)
1.62M
AAZAzincourt Energy Corp
$ 0.02
(0.00%)
1.04M
BOATThe Limestone Boat Company Limited
$ 0.005
(0.00%)
956.6k
TUKTuktu Resources Ltd
$ 0.095
(0.00%)
738.32k

Discussion

View Full Feed
Triple nickle Triple nickle 3 minutes ago
Not to shabby a spike
NCNC
88TH MAN 88TH MAN 3 minutes ago
I have always been committed. I am "All In". I am holding!
FBEC
ProLiberty ProLiberty 3 minutes ago
Next up is Italy... both approval and reimbursement expected / possible before year end.
AMRN
peafunke peafunke 3 minutes ago
Let’s go Jake …


When is the ride ?
TPTW
bob4uall bob4uall 3 minutes ago
Edward, is your Board broken this morning? I’m not seeing my reply.
BZWR
SkeBallLarry SkeBallLarry 4 minutes ago
" Am passing that on, CT ~ guess I missed it " .. !!
bunda bunda 4 minutes ago
you mama got kick by finra fuc-er
IGPK
John Doe 2024 John Doe 2024 4 minutes ago
That will never happen.
XERI
Hercules1 Hercules1 4 minutes ago
this is not closing under .004 today.


next station is .005.
HIRU
ExtremelyBullishZig ExtremelyBullishZig 4 minutes ago
Actually, they have been pointing it out for years since the beginning as the stat to watch .Maybe you should have been paying attention during the P2a.
AVXL
chonrm chonrm 4 minutes ago
Loser Leslie killed this with incompetence. What do you expect with that stupid looking snake oil salesman mustache.
INQD
ducci1 ducci1 4 minutes ago
Ridin 554C ,56 on 1st Vix By Sig ---think out at R2 !
SPY
work-n-hard work-n-hard 4 minutes ago
Woops. lol
SGMO
jimmybob jimmybob 4 minutes ago
$FVRR callllssssss
FVRR
Savannah-Marc Savannah-Marc 4 minutes ago
Last call to own shares before the Tobique deal approves, last call.
RONN
redspinelpinktopaz redspinelpinktopaz 4 minutes ago
Can't buy shares, with news about to be released.
LWLG
Carjockey2 Carjockey2 4 minutes ago
"GARD" is a Buy Signal remember same thing at .0022
HIRU
surfer44 surfer44 5 minutes ago
It looks like it may be similar to this book.

https://youtu.be/4N3YIcFsHy4
ExtremelyBullishZig ExtremelyBullishZig 5 minutes ago
Safety record schmafety record...you are missing the point. You are missing the main point. Water is safe too...it doesn't fix AD...the approved drugs have proven to slow the decline in large populations...so they get the approval.

If people including our CEO would follow rules, we wo
AVXL
Hosai Hosai 5 minutes ago
Yes all true but I would remind that 24% of placebo patients didn't finish trial either.
In a sense the 2:1 drug ratio perhaps helped in this context of things that it means with the smaller trial and drop outs there was still more data for patients on drug than if it had been 1:1.
In
AVXL
Starlost Starlost 5 minutes ago
https://twitter.com/CoinCitadelCCTL/status/1818469175951610029
CCTL
Itchy palm Itchy palm 5 minutes ago
Sounds like a Steve Bannon line fascist piece of 💩
LandPro LandPro 5 minutes ago
Always good to see a new cheerleader show up,LOL... won't help.
BLLB
janetcanada janetcanada 5 minutes ago
Good morning Sylvia, ***I Believe that Life Has a Way to "Teach Us Lesson"!.....

And YES I agree that Sooner or Later what Goes Around come Around!......

Wishing a Good Day

Take Care
janet
GRST

Your Recent History

TSXV
VCG
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved